Financials

News Discussions Technicals Seasonals

AMMCF fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

CRISM Therapeutics Corp. engages in the development of cancer treatment drugs for solid tumors. The firm offers ChemoSeed, which is a biodegradable drug delivery technology designed for the delivery of chemotherapy directly into cancer tissue. Its services include formulation and consultancy. The company was founded in March 2016 and is headquartered in Road Town, British Virgin Islands.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

AMMCF does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company